DK1337549T3 - Fremgangsmåde til foldning af kemisk syntetiserede polypeptider - Google Patents

Fremgangsmåde til foldning af kemisk syntetiserede polypeptider

Info

Publication number
DK1337549T3
DK1337549T3 DK01990489T DK01990489T DK1337549T3 DK 1337549 T3 DK1337549 T3 DK 1337549T3 DK 01990489 T DK01990489 T DK 01990489T DK 01990489 T DK01990489 T DK 01990489T DK 1337549 T3 DK1337549 T3 DK 1337549T3
Authority
DK
Denmark
Prior art keywords
chemically synthesized
folding
synthesized polypeptides
cysteine
reducing agent
Prior art date
Application number
DK01990489T
Other languages
English (en)
Inventor
Antonio Verdini
Giampietro Corradin
Mario Roggero
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Application granted granted Critical
Publication of DK1337549T3 publication Critical patent/DK1337549T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK01990489T 2000-11-27 2001-11-27 Fremgangsmåde til foldning af kemisk syntetiserede polypeptider DK1337549T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00204207 2000-11-27

Publications (1)

Publication Number Publication Date
DK1337549T3 true DK1337549T3 (da) 2006-07-31

Family

ID=8172340

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01990489T DK1337549T3 (da) 2000-11-27 2001-11-27 Fremgangsmåde til foldning af kemisk syntetiserede polypeptider

Country Status (22)

Country Link
US (2) US20020082384A1 (da)
EP (2) EP1337549B1 (da)
JP (1) JP2004516300A (da)
KR (1) KR20030081315A (da)
CN (2) CN1249078C (da)
AT (1) ATE322501T1 (da)
AU (2) AU2960302A (da)
BR (1) BR0113091A (da)
CA (1) CA2416054A1 (da)
CU (1) CU23034A3 (da)
DE (1) DE60118598T2 (da)
DK (1) DK1337549T3 (da)
ES (1) ES2261509T4 (da)
HU (1) HUP0302395A3 (da)
IL (1) IL155506A0 (da)
MX (1) MXPA03003576A (da)
NO (1) NO20032356D0 (da)
NZ (1) NZ523679A (da)
PL (1) PL364932A1 (da)
RU (1) RU2275377C2 (da)
WO (1) WO2002050099A2 (da)
ZA (1) ZA200300642B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
KR20070083815A (ko) * 2004-10-26 2007-08-24 론자 아게 고체상 합성에서 ｓ-알킬-술페닐 보호기
EP1814573B1 (en) 2004-10-29 2016-03-09 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (fgf)
ES2449195T3 (es) 2005-01-10 2014-03-18 Ratiopharm Gmbh Factor estimulante de colonias de granulocitos glicopegilado
EP1871795A4 (en) 2005-04-08 2010-03-31 Biogenerix Ag COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
ES2553160T3 (es) * 2005-06-17 2015-12-04 Novo Nordisk Health Care Ag Reducción y derivatización selectivas de proteínas Factor VII transformadas por ingeniería que comprenden al menos una cisteína no nativa
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US20090081145A1 (en) * 2005-12-23 2009-03-26 Aplagen Gmbh Process for forming disulphide bridges
AU2007248855A1 (en) * 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
WO2008057683A2 (en) 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
EP2125863A1 (de) * 2006-12-23 2009-12-02 AplaGen GmbH Verfahren zur ausbildung von disulfidbrücken
KR20100016160A (ko) 2007-04-03 2010-02-12 바이오제너릭스 에이지 글리코페길화 ｇ―ｃｓｆ를 이용하는 치료 방법
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
ES2476690T3 (es) 2008-02-27 2014-07-15 Novo Nordisk A/S Moléculas conjugadas del Factor VIII
CN104844693B (zh) * 2015-06-10 2018-08-03 成都圣诺生物科技股份有限公司 一种合成利那洛肽的方法
WO2019149918A1 (en) 2018-02-02 2019-08-08 Novo Nordisk A/S Drug injection device with deflectable transducer
CN111100188A (zh) * 2018-10-25 2020-05-05 成都医学院 一种制备蜘蛛抗菌肽的方法
CN109593119A (zh) * 2019-01-27 2019-04-09 上海丽珠制药有限公司 一种[2-d-组氨酸]-醋酸亮丙瑞林的制备方法
JP7453745B2 (ja) * 2019-03-28 2024-03-21 株式会社ヤクルト本社 毒性タンパク質の活性を阻害するペプチドのスクリーニング方法及び毒性タンパク質の製造方法
CN110845595A (zh) * 2019-11-14 2020-02-28 连云港职业技术学院 一种固相合成5-tmara标记的铁调素-25的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923787A1 (de) * 1979-06-12 1980-12-18 Max Planck Gesellschaft Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
DE3236849A1 (de) * 1982-10-05 1984-04-05 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue thiohydrazin-1,2-dicarbonsaeure-derivate, verfahren zu ihrer herstellung und ihre verwendung
IL96682A0 (en) * 1989-12-15 1991-09-16 Amgen Inc Production of biologically active platelet-derived growth factor from high expression host cell systems
CA2072249C (en) * 1991-06-28 2003-06-17 Saiko Hosokawa Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
EP0628573A1 (en) * 1993-05-24 1994-12-14 Kao Corporation Process for producing solubilized protein
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
DE4431317A1 (de) * 1994-09-02 1996-03-07 Biotechnolog Forschung Gmbh Schutz- bzw. Ankergruppen und deren Verwendung

Also Published As

Publication number Publication date
JP2004516300A (ja) 2004-06-03
WO2002050099A2 (en) 2002-06-27
RU2275377C2 (ru) 2006-04-27
AU2002229603B2 (en) 2007-11-08
MXPA03003576A (es) 2003-10-14
US20050239162A1 (en) 2005-10-27
EP1337549B1 (en) 2006-04-05
IL155506A0 (en) 2003-11-23
WO2002050099A3 (en) 2002-09-19
US20020082384A1 (en) 2002-06-27
DE60118598T2 (de) 2007-02-15
HUP0302395A3 (en) 2007-05-02
CN1830999A (zh) 2006-09-13
PL364932A1 (en) 2004-12-27
ES2261509T4 (es) 2008-02-16
ATE322501T1 (de) 2006-04-15
AU2960302A (en) 2002-07-01
NZ523679A (en) 2005-10-28
CA2416054A1 (en) 2002-06-27
CN1449406A (zh) 2003-10-15
EP1679318A1 (en) 2006-07-12
KR20030081315A (ko) 2003-10-17
CU23034A3 (es) 2005-03-22
DE60118598D1 (de) 2006-05-18
ES2261509T3 (es) 2006-11-16
NO20032356L (no) 2003-05-26
BR0113091A (pt) 2003-07-08
ZA200300642B (en) 2004-07-16
CN1249078C (zh) 2006-04-05
HUP0302395A2 (hu) 2003-10-28
NO20032356D0 (no) 2003-05-26
EP1337549A2 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
DK1337549T3 (da) Fremgangsmåde til foldning af kemisk syntetiserede polypeptider
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
BR0108164A (pt) Uso de pelo menos uma protease estável em ácido, processo para melhorar o valor nutritivo de um alimento para animal, aditivo de alimento para animal, composição de alimento para animal, e, processo para tratar proteìnas vegetais
IL161016A (en) Polypeptides capable of ang-2 binding
DE50114712D1 (de) Verfahren zum Debuggen von Programmen für industrielle Steuerungen, insbesondere Bewegungssteuerungen, im Kontext der Flow Chart Programmierung
ES2062812T3 (es) Composicion detergente enzimatica y metodo para estabilizar enzimas.
NO20005637D0 (no) Hybridprotein for å inhibere degranulasjon av mastocyter og anvendelsen derav
WO2002018583A3 (en) Modified polypeptides stabilized in a desired conformation and methods for producing same
PT94633A (pt) Metodo para a desnaturacao oxidante de analitos de proteina
BR9709569B1 (pt) processo para ativação de proteìna desnaturada.
NO20026128D0 (no) Gelformet drivstoff, fremgangsmåte for dets fremstilling og dets anvendelse
DE60222759D1 (de) Proteinsyntheseverfahren mit zellfreiem proteinsynthesesystem
WO2001081375A3 (en) Dna & protein binding miniature proteins
ATE461935T1 (de) Verfahren zur reinigung von stark anionischen proteinen
DE60220658D1 (de) Verfahren zur produktion von 2,6-dihalogenopurinen
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
DK1392126T3 (da) Fremgangsmåde til forbedring af et proteinprodukt
WO2003014144A3 (en) Molecule
IL162133A0 (en) Method of increasing protein expression, proteins and polynucleotides
DK0994187T3 (da) Renin-aktivt stof omfattende humant prorenin og antistoffer mod prorenin-profragmentet
ES2176814T3 (es) Recuperacion de proteinas mediante precipitacion usando lignosulfonatos.
ATE473241T1 (de) Neue hämpeptide
EP1385979A4 (en) METHOD FOR IMPROVING THE TRANSLATION AND EXPRESSION OF RECOMBINANT PROTEINS
AU2002257052A8 (en) Reg-like protein immunoglobulin derived proteins, compositions, methods and uses
ATE343631T1 (de) Methode zum stabilisieren von aspartataminotransferase und die entsprechenden zusammensetzungen